Incretin Therapy and Pancreatic Pathologies: Background Pathology Versus Drug-Induced Pathology in Rats. Diabetes 2014;63:1174–1178
In the commentary listed above, which appeared in the April 2014 issue of Diabetes, one of the authors did not disclose a financial conflict of interest. Dr. Josephine M. Egan is listed as an inventor on patents (US 7576050 and US 7056734) covering molecules described in the article. The reviewers and the editors were unaware of this interest at the time the manuscript was reviewed.
The online version reflects this change.
- © 2014 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.